Thyroid function in β-thalassemic children receiving hypertransfusions with suboptimal iron-chelating therapy

Journal of the Medical Association of Thailand

Volumn 90, Issue 9, 2007, Pages 1798-1802

  Jaruratanasirikul, Somchit ^a   Wongcharnchailert, Malai ^a   Laosombat, Vichai ^a   Sangsupavanich, Pasuree ^a   Leetanaporn, Kalaya ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

Hypothyroidism; Subclinical hypothyroidism; Thalassemia; Thyroid dysfunction

Indexed keywords

DEFEROXAMINE; THYROID ANTIBODY; THYROTROPIN; THYROXINE;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; FEMALE; FOLLOW UP; FREE THYROXINE INDEX; HUMAN; HYPOTHYROIDISM; IRON CHELATION; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL;

ADOLESCENT; AGE FACTORS; BETA-THALASSEMIA; BLOOD TRANSFUSION; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IRON CHELATING AGENTS; MALE; RISK FACTORS; THYROID DISEASES; THYROID GLAND; THYROTROPIN; THYROXINE;

EID: 35848970080     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Nathalang O, Arnutti P, Nillakupt K. Thalassemia screening among Royal Thai Army medical cadets. Mil Med 2004; 169: 274-6.
2. Pansatiankul B, Saisorn S. A community-based thalassemia prevention and control model in northern Thailand. J Med Assoc Thai 2003; 86(Suppl 3): S576-82.
3. Mohammadian S, Bazrafshan HR, Sadeghi-Nejad A. Endocrine gland abnormalities in thalassemia major: a brief review. J Pediatr Endocrinol Metab 2003; 16: 957-64.
4. Tiosano D, Hochberg Z. Endocrine complications of thalassemia. J Endocrinol Invest 2001; 24: 716-23.
5. Low LC. Growth, puberty and endocrine function in beta-thalassaemia major. J Pediatr Endocrinol Metab 1997; 10: 175-84.
6. Pantelakis S. Thyroid disorders and diabetes mellitus as complications of thalassaemia major. Acta Paediatr Suppl 1994; 406: 111-3.
7. Flynn DM, Fairney A, Jackson D, Clayton BE. Hormonal changes in thalassaemia major. Arch Dis Child 1976; 51: 828-36.
8. Costin G, Kogut MD, Hyman CB, Ortega JA. Endocrine abnormalities in thalassemia major. Am J Dis Child 1979; 133: 497-502.
9. de Luca F, Melluso R, Sobbrio G, Canfora G, Trimarchi F. Thyroid function in thalassaemia major. Arch Dis Child 1980; 55: 389-92.
10. Sabato AR, de S V, Atti G, Capra L, Bagni B, Vullo C. Primary hypothyroidism and the low T3 syndrome in thalassaemia major. Arch Dis Child 1983; 58: 120-7.
11. Masala A, Meloni T, Gallisai D, Alagna S, Rovasio PP, Rassu S, et al. Endocrine functioning in multitransfused prepubertal patients with homozygous beta-thalassemia. J Clin Endocrinol Metab 1984; 58: 667-70.
12. Oerter KE, Kamp GA, Munson PJ, Nienhuis AW, Cassorla FG, Manasco PK. Multiple hormone deficiencies in children with hemochromatosis. J Clin Endocrinol Metab 1993; 76: 357-61.
13. Grundy RG, Woods KA, Savage MO, Evans JP. Relationship of endocrinopathy to iron chelation status in young patients with thalassaemia major. Arch Dis Child 1994; 71: 128-32.
14. Gulati R, Bhatia V, Agarwal SS. Early onset of endocrine abnormalities in beta-thalassemia major in a developing country. J Pediatr Endocrinol Metab 2000; 13: 651-6.
15. Cario H, Stahnke K, Sander S, Kohne E. Epidemiological situation and treatment of patients with thalassemia major in Germany: results of the German multicenter beta-thalassemia study. Ann Hematol 2000; 79: 7-12.
16. Zervas A, Katopodi A, Protonotariou A, Livadas S, Karagiorga M, Politis C, et al. Assessment of thyroid function in two hundred patients with beta-thalassemia major. Thyroid 2002; 12: 151-4.
17. Aydinok Y, Darcan S, Polat A, Kavakli K, Nigli G, Coker M, et al. Endocrine complications in patients with beta-thalassemia major. J Trop Pediatr 2002; 48: 50-4.
18. Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vecchio GC, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 2004; 89: 1187-93.
19. Borgna-Pignatti C, Cappellini MD, De Stefano P, Del Vecchio GC, Forni GL, Gamberini MR, et al. Survival and complications in thalassemia. Ann NY Acad Sci 2005; 1054: 40-7.
20. De Sanctis V, Roos M, Gasser T, Fortini M, Raiola G, Galati MC. Impact of long-term iron chelation therapy on growth and endocrine functions in thalassaemia. J Pediatr Endocrinol Metab 2006; 19: 471-80.
21. Nutrition Division, Department of Health, Ministry of Public Health, Thailand. National growth references for children under 20 years of age. Bangkok: War Veterans Organization; 1999.
22. Landau H, Matoth I, Landau-Cordova Z, Goldfarb A, Rachmilewitz EA, Glaser B. Cross-sectional and longitudinal study of the pituitary-thyroid axis in patients with thalassaemia major. Clin Endocrinol (Oxf) 1993; 38: 55-61.